SLC7A11 and cancer: For example, genetic ablation or pharmacological inhibition of SLC7A11 strongly induces ferroptosis in various cancer cell types, whereas SLC7A11 overexpression in cancer cells promotes glutathione biosynthesis, confers ferroptosis resistance, and is associated with unfavorable patient outcomes [12].